← Back to Search

Active TMS stimulation for Schizophrenia

N/A
Waitlist Available
Led By Xiaoming Du, MD
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights

Study Summary

This trial is testing whether transcranial magnetic stimulation can help people with schizophrenia quit smoking, by measuring changes in brain function and connectivity.

Eligible Conditions
  • Schizophrenia
  • Smoking Cessation
  • Nicotine Addiction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cigarette Per Day
Secondary outcome measures
Cotinine
End-expired Carbon Monoxide (CO)
Functional Magnetic Resonance Imaging (fMRI)
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active TMS stimulationActive Control1 Intervention
Real active rTMS stimulation.
Group II: Sham TMS stimulationPlacebo Group1 Intervention
Sham repetitive TMS stimulation.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,687 Total Patients Enrolled
50 Trials studying Schizophrenia
5,123 Patients Enrolled for Schizophrenia
University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,612 Total Patients Enrolled
66 Trials studying Schizophrenia
10,213 Patients Enrolled for Schizophrenia
Xiaoming Du, MDPrincipal InvestigatorUniversity of Maryland, Baltimore

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Circuitry-Guided Smoking Cessation in Schizophrenia
Xiaoming Du 2018. "Circuitry-Guided Smoking Cessation in Schizophrenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03281629.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top